Company news
Firefly Neuroscience, Inc. news in 2024
Firefly Neuroscience, Inc.'s news releases, calls and decks from 2024, newest first.
Firefly Neuroscience Closes on Financing of up to $12.4 Million
December 30, 2024
Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman
December 3, 2024
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
November 13, 2024
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 24, 2024
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder
October 14, 2024
Firefly Neuroscience Advances AI-Driven BNA™ Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis
September 19, 2024
Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform
September 9, 2024
Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors
September 4, 2024
Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders
August 20, 2024
Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer
June 19, 2024
Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer
May 28, 2024
Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, David Johnson as Executive Chairman, Upon Closing of Its Merger Transaction with WaveDancer
May 13, 2024
FireFly Neuroscience Announces Healthcare Science and AI Industry Leader David DeCaprio to Join Board of Directors
April 16, 2024